Home/Filings/4/0000950170-25-002372
4//SEC Filing

Kooij Louise Frederika 4

Accession 0000950170-25-002372

CIK 0001936258other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:56 PM ET

Size

5.5 KB

Accession

0000950170-25-002372

Insider Transaction Report

Form 4
Period: 2025-01-02
Kooij Louise Frederika
Chief Accounting Officer
Transactions
  • Award

    Option (right to buy)

    2025-01-02+80,00080,000 total
    Exercise: $25.96Exp: 2035-01-02Ordinary Shares (80,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option will vest on January 2, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Documents

1 file

Issuer

NewAmsterdam Pharma Co N.V.

CIK 0001936258

Entity typeother

Related Parties

1
  • filerCIK 0002004379

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:56 PM ET
Size
5.5 KB